Ardent Health, Inc. $ARDT Shares Sold by Peregrine Capital Management LLC

Peregrine Capital Management LLC lowered its position in Ardent Health, Inc. (NYSE:ARDT) by 3.2% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 313,041 shares of the company’s stock after selling 10,494 shares during the quarter. Peregrine Capital Management LLC owned 0.22% of Ardent Health worth $4,276,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in ARDT. CWM LLC lifted its holdings in Ardent Health by 990.6% in the 2nd quarter. CWM LLC now owns 2,203 shares of the company’s stock worth $30,000 after buying an additional 2,001 shares in the last quarter. Morse Asset Management Inc bought a new stake in shares of Ardent Health in the 1st quarter worth about $36,000. Quarry LP increased its position in shares of Ardent Health by 1,519.4% in the 1st quarter. Quarry LP now owns 5,020 shares of the company’s stock worth $69,000 after purchasing an additional 4,710 shares during the last quarter. Deutsche Bank AG increased its position in shares of Ardent Health by 140.1% in the 1st quarter. Deutsche Bank AG now owns 6,882 shares of the company’s stock worth $95,000 after purchasing an additional 4,016 shares during the last quarter. Finally, Y Intercept Hong Kong Ltd bought a new stake in shares of Ardent Health in the 1st quarter worth about $142,000.

Ardent Health Price Performance

Shares of NYSE:ARDT opened at $15.11 on Wednesday. The company has a quick ratio of 2.00, a current ratio of 2.13 and a debt-to-equity ratio of 0.66. Ardent Health, Inc. has a fifty-two week low of $10.10 and a fifty-two week high of $18.85. The firm has a 50-day simple moving average of $13.58 and a 200 day simple moving average of $13.22. The company has a market cap of $2.16 billion, a PE ratio of 8.35, a P/E/G ratio of 6.69 and a beta of 0.39.

Ardent Health (NYSE:ARDT) last announced its quarterly earnings data on Tuesday, August 5th. The company reported $0.52 earnings per share for the quarter, beating analysts’ consensus estimates of $0.30 by $0.22. Ardent Health had a net margin of 4.11% and a return on equity of 16.66%. The business had revenue of $1.65 billion during the quarter, compared to the consensus estimate of $1.54 billion. Ardent Health has set its FY 2025 guidance at 1.730-2.01 EPS. On average, sell-side analysts anticipate that Ardent Health, Inc. will post 1.23 EPS for the current year.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on the stock. Bank of America downgraded shares of Ardent Health from a “neutral” rating to an “underperform” rating and dropped their target price for the stock from $15.50 to $14.60 in a research report on Wednesday, July 16th. JPMorgan Chase & Co. dropped their target price on shares of Ardent Health from $18.00 to $15.00 and set a “neutral” rating for the company in a research report on Monday, August 11th. The Goldman Sachs Group assumed coverage on shares of Ardent Health in a research report on Tuesday, October 14th. They issued a “neutral” rating and a $19.00 target price for the company. KeyCorp dropped their target price on shares of Ardent Health from $24.00 to $20.00 and set an “overweight” rating for the company in a research report on Thursday, August 7th. Finally, UBS Group assumed coverage on shares of Ardent Health in a research report on Wednesday, September 10th. They issued a “buy” rating and a $17.00 target price for the company. Nine equities research analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $19.30.

Ardent Health Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.